The store will not work correctly when cookies are disabled.
4-[6-[(4-fluorophenyl)methyl]imidazo[1,2-b]pyridazin-3-yl]benzamide
ID: ALA3731192
Chembl Id: CHEMBL3731192
PubChem CID: 90480121
Max Phase: Preclinical
Molecular Formula: C20H15FN4O
Molecular Weight: 346.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1ccc(-c2cnc3ccc(Cc4ccc(F)cc4)nn23)cc1
Standard InChI: InChI=1S/C20H15FN4O/c21-16-7-1-13(2-8-16)11-17-9-10-19-23-12-18(25(19)24-17)14-3-5-15(6-4-14)20(22)26/h1-10,12H,11H2,(H2,22,26)
Standard InChI Key: VPBZVJSBZKCACU-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.37 | Molecular Weight (Monoisotopic): 346.1230 | AlogP: 3.23 | #Rotatable Bonds: 4 |
Polar Surface Area: 73.28 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.16 | CX LogP: 3.18 | CX LogD: 3.18 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.62 | Np Likeness Score: -1.42 |
References
1. (2014) Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5, |